Actionnariat et activité des initiés pour Chemomab Therapeutics Ltd. (CMMB): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.65 |
| Capitalisation | $16M |
| Bourse | NASDAQ |
| Pays | IL |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-08-27 | Cohen Neil Harris | S-Sale | 1,304 | $4K |
| 2026-08-28 | Cohen Neil Harris | S-Sale | 1,000 | $3K |
| 2026-03-16 | Cohen Neil Harris | A-Award | 5,172 | $11K |
| 2025-03-16 | Cohen Neil Harris | A-Award | 3,821 | $24K |
| 2024-03-18 | Cohen Neil Harris | A-Award | 2,520 | $7K |
| 2023-03-21 | Cohen Neil Harris | A-Award | 1,714 | $11K |
| 2022-03-07 | Cohen Neil Harris | A-Award | 1,705 | $24K |
| 2021-04-19 | Cohen Neil Harris | A-Award | 2,971 | $324K |
| 2020-07-16 | Cohen Neil Harris | A-Award | 172 | $9K |
| 2026-06-01 | Melincoff Gwen A | 8,621 | $16K |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $4.6M | $1.5M | $7.5M | $17.6M | $11.7M | $15.2M | $13.5M | $9.3M | $6.1M | $7.6M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | $24000 | $46.0M | $26.4M | $10.5M | $8.2M | $2.8M |
| Créances | $139009 | $88000 | $3.4M | $636000 | $74000 | $179000 | $459000 | $289000 | $263000 | $3.1M |
| Stocks | 0 | 0 | -$77000 | -$542 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $4.9M | $1.6M | $10.9M | $18.2M | $11.8M | $62.7M | $41.7M | $20.9M | $16.0M | $13.4M |
| Immobilisations Corporelles | $213321 | $219000 | $385000 | $1.4M | $580000 | $688000 | $580000 | $686980 | $525000 | $175997 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | 0 | $14000 | $14000 | $8020 | $14000 | 0 |
| Actifs Totaux | $5.6M | $2.1M | $12.8M | $19.8M | $12.5M | $64.4M | $43.1M | $22.2M | $17.0M | $13.8M |
| Dettes Fournisseurs | $106530 | $160001 | $395996 | $25000 | $93000 | $1.3M | $1.7M | $516000 | $633000 | $484992 |
| Dette à Court Terme | 0 | 0 | 0 | $391000 | $179000 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.4M | $2.7M | $2.7M | $4.1M | $1.3M | $2.6M | $6.7M | $4.8M | $3.2M | $1.5M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $2.4M | $2.7M | $3.0M | $4.8M | $1.7M | $2.9M | $6.8M | $5.2M | $3.4M | $1.5M |
| Réserves | -$52.7M | -$62.9M | -$78.3M | -$17.7M | -$23.7M | -$36.2M | -$63.8M | -$88.7M | -$102.6M | -$111.6M |
| Capitaux Propres | $3.3M | -$609000 | $9.8M | $12.4M | $10.8M | $61.5M | $36.2M | $17.0M | $13.5M | $12.3M |
| Dette Totale | 0 | 0 | 0 | $586000 | $607000 | $343000 | $214000 | $392000 | $324000 | 0 |
| Dette Nette | -$4.6M | -$1.5M | -$7.5M | -$17.0M | -$11.1M | -$60.8M | -$39.7M | -$19.4M | -$13.9M | -$10.4M |
| Fonds de Roulement | $2.5M | -$1.1M | $8.2M | $14.1M | $10.5M | $60.0M | $35.0M | $16.1M | $12.8M | $11.9M |
Santé financière
| Dette / Capitaux propres | 0.00 |
| Ratio de liquidité | 6.41 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -8.29 |
Rentabilité
| Rentabilité des capitaux propres | -70.81% |
| Rentabilité du capital investi | -91.65% |
| Rentabilité des actifs | -74.25% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: BIVI · CANF · CERO · ELAB · GLMD · INM · KZIA
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de CMMB: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions